Delayed capital equipment purchasing by customers
Hospitals, surgical centers, and physician offices may defer buying laser systems during recessionary or uncertain periods.
- Scope
- Revenue timing and order conversion
- Materiality
- high
IRIDEX Corporation
IRIDEX Corp is an ophthalmic medical technology company that develops and commercializes laser-based systems and related therapies for sight-threatening eye diseases. Its core focus is on glaucoma and retinal disorders, using proprietary MicroPulse and Endpoint Management technologies to deliver tissue-sparing treatment modes in select laser consoles.
−3,9 %
36,5 %
−8,4 %
+8,2 %
1.91
1.32
| % | |
|---|---|
| Glaucoma systems | 24% Laser-based products and treatment modes used to manage glaucoma, including Cyclo G6. |
| Retina systems | 59% Products and procedures used to treat retinal diseases and related eye conditions. |
| Other products | 16% Additional ophthalmic devices, accessories, and related product sales outside the core glaucoma and retina groups. |
| Services and support | 1% Service revenue and support activities tied to installed systems and customer use. |
IRIDEX sells primarily to eye-care providers that need capital equipment and treatment solutions for glaucoma and...
- Hospitals and surgical centersprimary
Buy ophthalmic laser systems for glaucoma and retina procedures, often as capital equipment tied to procedure volume.
- Physician officesprimary
Purchase systems for in-office treatment of sight-threatening eye conditions and to expand procedure offerings.
- International distributorssecondary
Buy or place products for resale outside the U.S., extending market reach and local service coverage.
- Clinicians and treatment centerssecondary
Adopt proprietary treatment modes because they can deliver low-energy, tissue-sparing therapy.
IRIDEX is headquartered in the United States, but it also sells internationally through distributors and direct end...
- •United States is the core market for capital equipment and procedures
- •International distributors expand reach into non-U.S. ophthalmology markets
- •German office supports direct euro-denominated end-user sales
- •Foreign exchange can affect pricing and reported profitability
- •International mix can pressure gross margin when sales shift abroad
IRIDEX is focused on commercializing its proprietary laser therapy technologies and expanding adoption in glaucoma and...
01
Increase adoption of proprietary treatment modesmedium-term
MicroPulse and Endpoint Management differentiate the company’s systems and support clinical adoption.
02
Strengthen retina and glaucoma commercial executionshort-term
Revenue growth depends on converting clinical demand into capital equipment purchases and procedure use.
03
Maintain liquidity and funding flexibilityshort-term
The company expects current cash to cover 12 months, but future growth may require additional capital.
04
Improve manufacturing and cost structuremedium-term
Gross margin is sensitive to manufacturing costs, product mix, and international mix.
IRIDEX is exposed to cyclical capital equipment demand, since hospitals and physician offices can delay purchases when...
Tariffs and trade-war related cost inflation
Imported components and cross-border sales can be affected by tariff changes and retaliatory actions.
- Scope
- Manufacturing costs and international demand
- Materiality
- high
Foreign exchange pressure on international sales
A stronger U.S. dollar can make products more expensive abroad and reduce demand or profitability in local markets.
- Scope
- International distributor and euro-denominated direct sales
- Materiality
- medium
Margin compression from product and geographic mix
Capital system sales and international mix can lower gross margin when manufacturing costs rise.
- Scope
- Gross profit and operating leverage
- Materiality
- high
Financing and dilution risk
The company may need additional capital for R&D, sales expansion, or manufacturing investment.
- Scope
- Liquidity and shareholder dilution
- Materiality
- medium
Revenue recognition by product and channel
Affects quarterly revenue timing and comparability
Inventory, warranty, and manufacturing cost estimates
Directly affects gross margin
Foreign currency effects
Can change reported revenue and profitability
Convertible preferred shares and convertible debt
Affects capital structure and per-share results
IRIDEX CORP
IRIX · Electromedical & Electrotherapeutic Apparatus
IRIDEX Corp is an ophthalmic medical technology company that develops and commercializes laser-based systems and related therapies for sight-threatening eye diseases.
IRADIMED CORP
IRMD · Surgical & Medical Instruments & Apparatus
IRADIMED Corp designs and sells MRI-compatible medical devices used inside scanner rooms, centered on infusion pumps, patient vital signs monitoring systems, and related disposables and service.
IR-Med, Inc.
Electromedical & Electrotherapeutic Apparatus
Nurix Therapeutics, Inc.
NRIX · Pharmaceutical Preparations
Nurix Therapeutics is a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing targeted protein degradation medicines.
IMMUNIC, INC.
IMUX · Pharmaceutical Preparations
ARDELYX, INC.
ARDX · Pharmaceutical Preparations
: 28/04/2026